■持续的HR-HPV导致宫颈癌,表现出地理差异。欧洲/美洲有更高的HPV16/18率,而亚洲/非洲主要是非16/18HR-HPV。这项研究在福建,亚洲,探索非16/18HR-HPV感染,评估他们的流行病学和宫颈病变相关性,以便有针对性地预防。
■共纳入2013年至2019年在福建省某医院接受HPV筛查的101,621名女性。进行HPV基因分型。分析了具有可用组织病理学结果的11,666名HPV阳性妇女的子集,以表征宫颈诊断中的HPV基因型分布。
■在101,621个样本中,24.5%的HPV检测呈阳性。在这些样本中,17.3%表现为单一感染,而7.2%的人显示有多重感染的证据。确定的主要非16/18高危HPV类型是HPV52、58、53、51和81。单一HPV感染占所有HPV阳性病例的64.1%,其中71.4%是非16/18高危型HPV感染。在11,666例HPV阳性患者的病理结果中观察到年龄相关的变化。癌症患者年龄较大。在癌症组中,HPV52(21.8%)和HPV58(18.6%)为主要类型,其次是HPV33、HPV31和HPV53。与单一HPV16/18感染相比,非16/18HPV在LSIL中占主导地位。LSIL的调整后比值比(OR)升高:多重HPV16/18(OR2.18),多重非16/18HR-HPV(OR2.53),和多重LR-HPV(OR2.38)。值得注意的是,单独的HPV16/18赋予更高的机会HSIL和癌症。
■我们在福建省的大规模分析强调HPV52、58、53、51和81是主要的非16/18HR-HPV类型。多种HPV会增加LSIL风险,而单独的HPV16/18会增加HSIL和癌症的几率。这些发现强调了量身定制的宫颈癌预防,强调HPV对病变严重程度的特定影响,并指导亚洲最佳筛查的区域特定策略,强调疫苗接种时代的持续监测。
UNASSIGNED: Persistent HR-HPV causes cervical cancer, exhibiting geographic variance. Europe/Americas have higher
HPV16/18 rates, while Asia/Africa predominantly have non-16/18 HR-
HPV. This study in Fujian, Asia, explores non-16/18 HR-HPV infections, assessing their epidemiology and cervical lesion association for targeted prevention.
UNASSIGNED: A total of 101,621 women undergoing HPV screening at a hospital in Fujian Province from 2013 to 2019 were included. HPV genotyping was performed. A subset of 11,666 HPV-positive women with available histopathology results were analyzed to characterize HPV genotype distribution across cervical diagnoses.
UNASSIGNED: In 101,621 samples, 24.5% tested positive for HPV. Among these samples, 17.3% exhibited single infections, while 7.2% showed evidence of multiple infections. The predominant non-16/18 high-risk HPV types identified were HPV 52, 58, 53, 51, and 81. Single HPV infections accounted for 64.1% of all HPV-positive cases, with 71.4% of these being non-16/18 high-risk HPV infections. Age-related variations were observed in 11,666 HPV-positive patients with pathological results. Cancer patients were older. In the cancer group, HPV52 (21.8%) and
HPV58 (18.6%) were the predominant types, followed by
HPV33,
HPV31, and HPV53. Compared to single
HPV16/18 infection, non-16/18
HPV predominated in LSIL. Adjusted odds ratios (OR) for LSIL were elevated: multiple
HPV16/18 (OR 2.18), multiple non-16/18 HR-
HPV (OR 2.53), and multiple LR-HPV (OR 2.38). Notably, solitary HPV16/18 conferred higher odds for HSIL and cancer.
UNASSIGNED: Our large-scale analysis in Fujian Province highlights HPV 52, 58, 53, 51, and 81 as predominant non-16/18 HR-HPV types. Multiple
HPV poses increased LSIL risks, while solitary
HPV16/18 elevates HSIL and cancer odds. These findings stress tailored cervical cancer prevention, highlighting specific HPV impacts on lesion severity and guiding region-specific strategies for optimal screening in Asia, emphasizing ongoing surveillance in the vaccination era.